Every Form 4 that CME Group (CME) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CME filings page.
Insider transactions at CME Group Inc. (CME)
Lynne Fitzpatrick, President and Chief Financial Officer, reported three Form 4 transactions related to restricted stock vesting on September 15-16, 2025. She surrendered 639 Class A shares on 09/15/2025 and 379 shares on 09/16/2025 to satisfy tax withholding obligations, at prices of $258.83 and $259.83 respectively. On 09/15/2025 she also acquired 4,348 Class A shares at $258.83, reflecting the net issuance from vesting. After these reported transactions, she beneficially owned 20,924 Class A shares directly.
Jack J. Tobin, MD Chief Accounting Officer of CME Group (CME), reported routine equity transactions tied to tax-withholding on vested restricted stock. The filing discloses three non-derivative transactions: on 09/15/2025 Mr. Tobin disposed of 143 shares at $258.83 to satisfy tax withholding and simultaneously acquired 1,546 shares at $258.83, leaving him with 25,142 shares after that activity. On 09/16/2025 he disposed of 57 shares at $259.83 for additional tax withholding, leaving 25,085 shares beneficially owned. The transactions are described as share surrenders to satisfy tax obligations upon vesting of restricted stock.
Michael G. Dennis, Global Head of Fixed Income at CME Group (CME), reported changes to his beneficial ownership in the company. On 09/15/2025 he acquired 2,608 Class A common shares at $258.83 each, bringing his direct holdings to 8,927.3766 shares. On 09/16/2025 he disposed of 289 shares at $259.83, leaving 8,638.3766 direct shares. The filing notes that the shares were surrendered to the company to satisfy tax withholding obligations upon the vesting of restricted stock on 09/16/2025. An additional 40.81 shares are held indirectly by his spouse.
Timothy Francis McCourt, Senior Managing Director, Global Head Equity & FX at CME Group Inc. (CME), reported changes in his beneficial ownership via a Form 4. On September 15, 2025 he surrendered 754 Class A shares to satisfy tax-withholding associated with restricted stock vesting and simultaneously acquired 2,752 Class A shares at $258.83 per share, bringing his direct holdings to 9,887 shares. On September 16, 2025 he surrendered an additional 379 shares at $259.83 per share for tax-withholding, leaving 9,508 shares beneficially owned after the transactions. The Form 4 was signed on behalf of Mr. McCourt on September 17, 2025.
Form 4 disclosure for Derek Sammann, Senior Managing Director, Global Head of Commodities Markets at CME Group (CME). The filing reports share surrender and vesting activity on September 15-16, 2025. Mr. Sammann surrendered 1,099 and 379 Class A shares to satisfy tax withholding obligations upon restricted stock vesting on those dates. The filing lists direct beneficial ownership amounts of 8,318; 11,362; and 10,983 Class A shares after respective transactions, and shows indirect holdings of 14,614 shares held by a trust and 8,336 shares held by his spouse. The form was signed on 09/17/2025.
Terrence A. Duffy, Chairman and CEO and a director of CME Group Inc. (CME), reported a purchase of 23,180 shares of Class A Common Stock on 09/15/2025 at a reported price of $258.83 per share. After the transaction he beneficially owns 90,804 shares. The Form 4 was signed on behalf of the reporting person by Margaret Austin Wright on 09/17/2025. No derivative transactions were reported.
Hilda Harris Piell, Sr. MD & Chief HR Officer at CME Group (CME), reported insider transactions on Form 4 showing share surrenders to cover tax withholding upon restricted stock vesting. On 09/15/2025 she disposed of 953 Class A shares at $258.83 each, reducing her holdings to 28,108 shares, and on the same date acquired 2,608 shares at $258.83, raising holdings to 30,716 shares. On 09/16/2025 she disposed of 325 shares at $259.83, leaving 30,391 shares beneficially owned after the reported transactions. The filing states the disposals were share surrenders to satisfy tax-withholding obligations tied to restricted stock vesting; the form was signed on 09/17/2025.